{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T16:17:19Z","timestamp":1776529039526,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lfs.2025.123442","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:49:03Z","timestamp":1738957743000},"page":"123442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["DLGAP5 upregulates E2F1 to promote prostate adenocarcinoma neuroendocrine differentiation"],"prefix":"10.1016","volume":"365","author":[{"given":"Linghui","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruizhe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2025.123442_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.lfs.2025.123442_bb0015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"Pt 3","key":"10.1016\/j.lfs.2025.123442_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2022.05.007","article-title":"Molecular mechanisms underlying the development of neuroendocrine prostate cancer","volume":"86","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"30","key":"10.1016\/j.lfs.2025.123442_bb0025","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.2013.54.3553","article-title":"Neuroendocrine prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis","volume":"32","author":"Wang","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13041-017-0324-9","article-title":"The DLGAP family: neuronal expression, function and role in brain disorders","volume":"10","author":"Rasmussen","year":"2017","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12967-024-04910-8","article-title":"DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2025.123442_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102081","article-title":"Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8(+)T cell infiltration in triple-negative breast cancer","volume":"49","author":"Pan","year":"2024","journal-title":"Transl. Oncol."},{"issue":"21","key":"10.1016\/j.lfs.2025.123442_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115819","article-title":"DLGAP5 regulates the proliferation, migration, invasion, and cell cycle of breast Cancer cells via the JAK2\/STAT3 signaling Axis","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2025.123442_bb0050","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41388-023-02932-y","article-title":"DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11","volume":"43","author":"Zhou","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2025.123442_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102081","article-title":"Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8(+)T cell infiltration in triple-negative breast cancer","volume":"49","author":"Pan","year":"2024","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12935-021-02155-9","article-title":"Pan-cancer analysis of the oncogenic role of discs large homolog associated protein 5 (DLGAP5) in human tumors","volume":"21","author":"Tang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.lfs.2025.123442_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.lfs.2025.123442_bb0070","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"37","key":"10.1016\/j.lfs.2025.123442_bb0075","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/s41388-022-02437-0","article-title":"Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer","volume":"41","author":"Wang","year":"2022","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.lfs.2025.123442_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11912-020-01003-9","article-title":"Clinical and biological features of neuroendocrine prostate Cancer","volume":"23","author":"Yamada","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.lfs.2025.123442_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103370","article-title":"Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype","volume":"163","author":"Tong","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0090","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1038\/s41467-020-19328-1","article-title":"Role of specialized composition of SWI\/SNF complexes in prostate cancer lineage plasticity","volume":"11","author":"Cyrta","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.lfs.2025.123442_bb0095","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/1541-7786.MCR-19-1245","article-title":"Targeting RET kinase in neuroendocrine prostate Cancer","volume":"18","author":"VanDeusen","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123442_bb0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1158\/1078-0432.CCR-18-0729","article-title":"Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate Cancer","volume":"25","author":"Flores-Morales","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2025.123442_bb0105","doi-asserted-by":"crossref","first-page":"1191311","DOI":"10.3389\/fendo.2023.1191311","article-title":"Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution","volume":"14","author":"Imamura","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"21","key":"10.1016\/j.lfs.2025.123442_bb0110","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1158\/1078-0432.CCR-19-0498","article-title":"BRN4 is a novel driver of neuroendocrine differentiation in castration-resistant prostate Cancer and is selectively released in extracellular vesicles with BRN2","volume":"25","author":"Bhagirath","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"27","key":"10.1016\/j.lfs.2025.123442_bb0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203820119","article-title":"Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer","volume":"119","author":"Korsen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.lfs.2025.123442_bb0120","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.euf.2018.04.006","article-title":"Primary mutational landscape linked with pre-docetaxel lactate dehydrogenase levels predicts docetaxel response in metastatic castrate-resistant prostate Cancer","volume":"5","author":"Hiew","year":"2019","journal-title":"Eur. Urol. Focus"},{"issue":"14","key":"10.1016\/j.lfs.2025.123442_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16142503","article-title":"ENO2, a glycolytic enzyme, contributes to prostate Cancer metastasis: a systematic review of literature","volume":"16","author":"Zhou","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"28","key":"10.1016\/j.lfs.2025.123442_bb0130","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1038\/onc.2017.50","article-title":"FOXA1 inhibits prostate cancer neuroendocrine differentiation","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pros.10217","article-title":"Molecular characterization of prostatic small-cell neuroendocrine carcinoma","volume":"55","author":"Clegg","year":"2003","journal-title":"Prostate"},{"issue":"17","key":"10.1016\/j.lfs.2025.123442_bb0140","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1021\/acs.jmedchem.9b00353","article-title":"Discovery of inhibitors of Aurora\/PLK targets as anticancer agents","volume":"62","author":"Qi","year":"2019","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2025.123442_bb0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41585-021-00490-0","article-title":"Molecular events in neuroendocrine prostate cancer development","volume":"18","author":"Wang","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123442_bb0150","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1158\/0008-5472.CAN-17-1924","article-title":"Single-cell RNA-seq reveals a subpopulation of prostate Cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response","volume":"78","author":"Horning","year":"2018","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.lfs.2025.123442_bb0155","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1111\/cas.14183","article-title":"Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer","volume":"110","author":"Yamamoto","year":"2019","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.lfs.2025.123442_bb0160","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41419-018-1115-7","article-title":"A functional genomics screen reveals a strong synergistic effect between docetaxel and the mitotic gene DLGAP5 that is mediated by the androgen receptor","volume":"9","author":"Hewit","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188336","article-title":"The conflicting role of E2F1 in prostate cancer: a matter of cell context or interpretational flexibility?","volume":"1873","author":"Chun","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"11","key":"10.1016\/j.lfs.2025.123442_bb0170","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188336","article-title":"The conflicting role of E2F1 in prostate cancer: a matter of cell context or interpretational flexibility?","volume":"1873","author":"Chun","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/path.6325","article-title":"Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1-SNAI1 axis","volume":"264","author":"Wang","year":"2024","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2025.123442_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217090","article-title":"Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer","volume":"598","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.lfs.2025.123442_bb0190","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/1078-0432.CCR-20-4968","article-title":"BET Bromodomain inhibition blocks an AR-repressed, E2F1-activated treatment-emergent neuroendocrine prostate Cancer lineage plasticity program","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2025.123442_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107377","article-title":"BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer","volume":"208","author":"Liu","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.lfs.2025.123442_bb0200","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.14336\/AD.2023.0202","article-title":"Overexpression of RACGAP1 by E2F1 promotes neuroendocrine differentiation of prostate Cancer by stabilizing EZH2 expression","volume":"14","author":"Song","year":"2023","journal-title":"Aging Dis."},{"issue":"24","key":"10.1016\/j.lfs.2025.123442_bb0205","doi-asserted-by":"crossref","first-page":"11897","DOI":"10.1158\/0008-5472.CAN-06-2497","article-title":"Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer","volume":"66","author":"Davis","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0210","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1038\/s41467-022-32701-6","article-title":"Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity","volume":"13","author":"Westbrook","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2025.123442_bb0215","doi-asserted-by":"crossref","first-page":"13786","DOI":"10.1038\/s41598-019-50220-1","article-title":"Drivers of AR indifferent anti-androgen resistance in prostate cancer cells","volume":"9","author":"Handle","year":"2019","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.lfs.2025.123442_bb0220","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/0008-5472.CAN-23-0015","article-title":"LncRNA AGPG confers endocrine resistance in breast Cancer by promoting E2F1 activity","volume":"83","author":"Yu","year":"2023","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.lfs.2025.123442_bb0225","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1038\/onc.2010.333","article-title":"Biological reprogramming in acquired resistance to endocrine therapy of breast cancer","volume":"29","author":"Aguilar","year":"2010","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.lfs.2025.123442_bb0230","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1158\/0008-5472.CAN-15-2383","article-title":"HER2 signaling drives DNA anabolism and proliferation through SRC-3 phosphorylation and E2F1-regulated genes","volume":"76","author":"Nikolai","year":"2016","journal-title":"Cancer Res."},{"issue":"Database issue","key":"10.1016\/j.lfs.2025.123442_bb0235","first-page":"D955","article-title":"Genomics of drug sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.lfs.2025.123442_bb0240","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2025.123442_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217214","article-title":"Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy","volume":"602","author":"He","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052500075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052500075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T14:43:53Z","timestamp":1740494633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052500075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"alternative-id":["S002432052500075X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123442","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DLGAP5 upregulates E2F1 to promote prostate adenocarcinoma neuroendocrine differentiation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123442"}}